A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines. Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system. We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit™. Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities. Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities. These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of defined culture media with recombinant proteins instead of whole animal serum greatly increases process comparability and supply chain assurance [67,68,69].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [68]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene-modified therapies, including iPSC-derived products and CAR-T cells, present distinct biosafety and technical challenges for POC implementation (Nakagawa et al., 2014; Moradi et al., 2023).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Nakagawa et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061 · cited 3×
“Moreover, hiPSCs were successfully established from primary fibroblasts, peripheral blood and cord blood under these conditions using episomal vectors 16,17 .”
BackgroundMethodA ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Self-citationFeeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,870
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447 · cited 2×
“In addition, it is necessary to use defined culture system for the source of iPS cells, such as fibroblasts or blood cells 13,23 .”
BackgroundMethodEmbryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Research works printed but not linked: 1
- Grigoriadis, A. E. et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115, 2769–2776 (2010). · DOI · Paper page
Cited by
Items 301–400 of 675
Optimal human iPS cell culture method for efficient hepatic differentiation
Matoba, N., Yamashita, T., Takayama, K., Sakurai, F., & Mizuguchi, H. (2018) · Differentiation · doi:10.1016/j.diff.2018.09.005 · Cited by 14
Automated adherent cell elimination by a high-speed laser mediated by a light-responsive polymer
Hayashi, Y., Matsumoto, J., Kumagai, S., Morishita, K., Xiang, L., Kobori, Y., Hori, S., Suzuki, M., Kanamori, T., Hotta, K., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0222-4 · Cited by 14
Baboon induced pluripotent stem cell generation bypiggyBactransposition of reprogramming factors
Rodríguez-Polo, I., Stauske, M., Becker, A., Bartels, I., Dressel, R., & Behr, R. (2019) · Primate Biology · doi:10.5194/pb-6-75-2019 · Cited by 15
Lee, H.-A., Nam, D., Choi, J.-K., Araúzo-Bravo, M. J., Kwon, S.-Y., Zaehres, H., Lee, T., Park, C. Y., Kang, H.-W., Schöler, H. R., et al. (2016) · Scientific Reports · doi:10.1038/srep20708 · Cited by 14
Ahmadian Baghbaderani, B., Tian, X., Scotty Cadet, J., Shah, K., Walde, A., Tran, H., Kovarcik, D. P., Clarke, D., & Fellner, T. (2016) · PLOS ONE · doi:10.1371/journal.pone.0161229 · Cited by 13
“The prolonged stability and effectiveness of the TS bFGF at 37°C allows lower concentrations of bFGF to be used in the cultivation of hPSCs and eliminates the need for any animal-derived components such as porcine heparin [11,30,31].”
BackgroundIdeno, H., Imaizumi, K., Shimada, H., Sanosaka, T., Nemoto, A., Kohyama, J., & Okano, H. (2022) · iScience · doi:10.1016/j.isci.2022.105140 · Cited by 15
“The contamination of mouse-derived cells is also unfavorable for the clinical application of PSCs. Recent advances have made it possible to maintain PSCs without feeder cells under defined culture conditions (Chen et al., 2011; Ludwig et al., 2006; Nakagawa et al., 2015).”
BackgroundMethodInfluentialKanemura, Y., Yamamoto, A., Katsuma, A., Fukusumi, H., Shofuda, T., Kanematsu, D., Handa, Y., Sumida, M., Yoshioka, E., Mine, Y., et al. (2024) · Cells · doi:10.3390/cells13080671 · Cited by 13
“…hiPSCs, clone Ff-WJ14s01 (Supplementary Figure S1), established from umbilical cord blood cells using an integration-free reprogramming method [37,39] and a feeder-free protocol [40] at the Center for iPS Cell Research and Application (CiRA), Kyoto University, were used to generate hiPSC-NPCs.”
MethodArai, Y., Takami, M., An, Y., Matsuo‐Takasaki, M., Hemmi, Y., Wakabayashi, T., Inoue, J., Noguchi, M., Nakamura, Y., Sugimoto, K., et al. (2020) · Stem Cell Research · doi:10.1016/j.scr.2020.101815 · Cited by 13
Kidney development and function: ECM cannot be ignored
Abdollahzadeh, F., Rad, N. K., & Moghadasali, R. (2022) · Differentiation · doi:10.1016/j.diff.2022.02.001 · Cited by 14
Nishimura, K., Nitta, T., Doi, K., & Takata, K. (2022) · Stem Cells and Development · doi:10.1089/scd.2021.0363 · Cited by 13
Naiki, Y., Miyado, M., Shindo, M., Horikawa, R., Hasegawa, Y., Katsumata, N., Takada, S., Akutsu, H., Onodera, M., & Fukami, M. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.005 · Cited by 13
Takii, S., Wu, J., & Okamura, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0259482 · Cited by 13
“In contrast, in the field of pluripotent stem cells, the use of serum-free and/or xeno-free medium has become standard [10].”
Tsujimoto, H., Katagiri, N., Ijiri, Y., Sasaki, B., Kobayashi, Y., Mima, A., Ryosaka, M., Furuyama, K., Kawaguchi, Y., & Osafune, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275600 · Cited by 13
Nishishita, N., Muramatsu, M., & Kawamata, S. (2015) · Europe PMC (PubMed Central) · Cited by 14
Matsuura, K., Ito, K., Shiraki, N., Kume, S., Hagiwara, N., & Shimizu, T. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0228 · Cited by 13
Yahata, N., Boda, H., & Hata, R. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.10.017 · Cited by 14
“These iPSCs were also cultured under feeder-free conditions, in accordance with a previous report.(32) After the feeder cells were removed using a CTK solution,(33) iPSCs were dissociated into single cells by incubation with 0.”
MethodKoc, A., Goktas, S. S., Çağlar, T. A., & Çağavi, E. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112599 · Cited by 14
CDK8/19 inhibition plays an important role in pancreatic β-cell induction from human iPSCs
Sakuma, K., Tsubooka-Yamazoe, N., Hashimoto, K., Sakai, N., Asano, S., Watanabe-Matsumoto, S., Watanabe, T., Saito, B., Matsumoto, H., Ueno, H., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03220-4 · Cited by 12
“The Ff-I14s04 line was established as an HLA homozygous iPSC line in a previous study [19].”
ResultTanabe, M., Saito, Y., Takasaki, A., Nakano, K., Yamamoto, S., Suzuki, C., Kawamura, N., Hattori, A., Oikawa, M., Nagashima, S., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115133 · Cited by 14
Chang, Y., Abe, K., Yokota, H., Sudo, K., Nakamura, Y., & Tsai, M. (2019) · Biomedical Engineering Applications Basis and Communications · doi:10.4015/s1016237219500091 · Cited by 12
Wakabayashi, S., Morihara, H., Yokoe, S., Nakagawa, T., Moriwaki, K., Tomoda, K., & Asahi, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010329 · Cited by 11
“These iPSCs were maintained in StemFit AK02N (Ajinomoto) medium on a plate coated with iMatrix511 silk (Nippi) and passaged every 5–7 days with Accutase (Innovative Cell Technologies) (40).”
MethodVitillo, L., Durance, C., Hewitt, Z., Moore, H. D. M., Smith, A. G., & Vallier, L. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01915-0 · Cited by 13
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
Sano, E., Deguchi, S., Sakamoto, A., Mimura, N., Hirabayashi, A., Muramoto, Y., Noda, T., Yamamoto, T., & Takayama, K. (2021) · iScience · doi:10.1016/j.isci.2021.102428 · Cited by 13
Modeling gap junction beta 2 gene-related deafness with human iPSC
Fukunaga, I., Oe, Y., Danzaki, K., Ohta, S., Chen, C., Shirai, K., Kawano, A., Ikeda, K., & Kamiya, K. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab097 · Cited by 15
Identification of BST2 as a conjunctival epithelial stem/progenitor cell marker
Kitao, M., Hayashi, R., Nomi, K., Kobayashi, R., Katayama, T., Takayanagi, H., Oguchi, A., Murakawa, Y., & Nishida, K. (2023) · iScience · doi:10.1016/j.isci.2023.107016 · Cited by 14
Zhang, L., Xu, Y., Xu, J., Wei, Y., & Xu, X. (2016) · Human Reproduction · doi:10.1093/humrep/dew011 · Cited by 13
Kitani‐Morii, F., Imamura, K., Kondo, T., Ohara, R., Enami, T., Shibukawa, R., Yamamoto, T., Sekiguchi, K., Toguchida, J., Mizuno, T., et al. (2017) · Neuroreport · doi:10.1097/wnr.0000000000000831 · Cited by 12
Tagawa, M., Ikeda, H. O., Inoue, Y., Iwai, S., Iida, Y., Hata, M., Asaka, I., & Tsujikawa, A. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108503 · Cited by 11
Uehara, K., Koyanagi‐Aoi, M., Koide, T., Itoh, T., & Aoi, T. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.002 · Cited by 12
“These hiPSC lines were cultured according to a previously described method (Nakagawa et al., 2015) with slight modifica-”
MethodIwasaki, M., Kawahara, Y., Okubo, C., Yamakawa, T., Nakamura, M., Tabata, T., Nishi, Y., Narita, M., Ohta, A., Saito, H., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104289 · Cited by 12
“A Rock inhibitor (Y-27632, final concentration, 10 mM) was used only on the day of plating (Nakagawa et al., 2014).”
MethodYamada, D., Iyoda, T., Shimizu, K., Sato, Y., Koseki, H., & Fujii, S. (2017) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2277 · Cited by 11
Urine-derived cells from the aged donor for the 2D/3D modeling of neural cells via iPSCs
Supakul, S., Hatakeyama, Y., Leventoux, N., Itsuno, M., Numata, N., Hiramine, H., Morimoto, S., Iwata, A., Maeda, S., & Okano, H. (2023) · Aging Brain · doi:10.1016/j.nbas.2023.100101 · Cited by 16
“In addition, the control iPSC line, 1210B2, was established from ePBMCs ® from the Cellular Technology Limited (OH, USA) at the Center for iPS Cell Research and Application (CiRA: Kyoto, Japan) by an integration-free method [18].”
BackgroundMethodChang, S.-H., & Park, C. (2023) · Immune Network · doi:10.4110/in.2023.23.e44 · Cited by 13
Construction of multilayered small intestine-like tissue by reproducing interstitial flow
Deguchi, S., Kosugi, K., Takeishi, N., Watanabe, Y., Morimoto, S., Negoro, R., Yokoi, F., Futatsusako, H., Nakajima‐Koyama, M., Iwasaki, M., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.06.012 · Cited by 13
Fukusumi, H., Handa, Y., Shofuda, T., & Kanemura, Y. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.08.002 · Cited by 11
Tsukamoto, S., Nakade, K., Wakabayashi, T., Nakashima, K., Takami, M., Hemmi, Y., Kuramochi, Y., Shimizu, T., Arai, Y., Matsuo‐Takasaki, M., et al. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102363 · Cited by 11
A stress-reduced passaging technique improves the viability of human pluripotent cells
Takahashi, K., Okubo, C., Nakamura, M., Iwasaki, M., Kawahara, Y., Tabata, T., Miyamoto, Y., Woltjen, K., & Yamanaka, S. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100155 · Cited by 15
“To resolve this issue, we modified the procedure of cell passaging and explored the effects on cell viability in detail using two independent iPSC lines, WTB6 (Miyaoka et al., 2014) and WTC11 (Kreitzer et al., 2013), maintained on laminin-511 E8 fragment in a chemically defined media, StemFit (Miyazaki et al., 2012; N…”
BackgroundMethodInfluentialTET1 facilitates specification of early human lineages including germ cells
Hsu, F., Wu, Q. Y., Fabyanic, E. B., Wei, A., Wu, H., & Clark, A. T. (2023) · iScience · doi:10.1016/j.isci.2023.107191 · Cited by 12
“Given that hPGCLC competency requires progenitors to remain in the germline trajectory, and hESCs cultured in KSR/MEF conditions exhibit spontaneous differentiation (Figures S5B and S5C), we evaluated whether hPGCLC induction in the catKO could be rescued by transitioning hESCs from KSR/MEFs to a defined media (StemFi…”
ResultThe occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 18
Yahata, N., Goto, Y., & Hata, R. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102521 · Cited by 12
Preparation, characterization, and banking of clinical-grade cells for neural transplantation
Natalwala, A., & Kunath, T. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2017.02.007 · Cited by 13
Saito, R., Miyajima, T., Iwamoto, T., Wu, C., Suzuki, K., Hossain, M. A., Munakata, M., Era, T., & Eto, Y. (2021) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2021.100784 · Cited by 12
Saito, Y., Nakamura, K., Yoshida, M., Sugiyama, H., Akagi, S., Miyoshi, T., Morita, H., & Ito, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02818-y · Cited by 10
“Then they were resupended in StemFit AK02N (Cat#. AK02N, Ajinomoto Healthy Supply, Tokyo, Japan) with 10 µmol/L Y-27632 (Cat#. S1049, Selleck Chemicals, Houston, TX, United States) and seeded at 1.5 × 103/cm2 on 0.25 µg/cm2 iMatrix-511 silk (Cat#. 892021, Matrixome, Osaka, Japan)-coated 6-well plates (Cat#. 3516, Corn…”
InfluentialMorimoto, Y., Tokumitsu, A., Sone, T., Hirota, Y., Tamura, R., Sakamoto, A., Nakajima, K., Toda, M., Kawakami, Y., Okano, H., et al. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03629-6 · Cited by 11
Sanosaka, T., Okuno, H., Mizota, N., Andoh-Noda, T., Sato, M., Tomooka, R., Banno, S., Kohyama, J., & Okano, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-27293-6 · Cited by 18
Kamakura, T., Jin, Y., Nishio, M., Nagata, S., Fukuda, M., Sun, L., Kawai, S., & Toguchida, J. (2023) · JBMR Plus · doi:10.1002/jbm4.10737 · Cited by 13
“Two hiPSC lines (414C2 and 1231A3) established at our institute((23,24)) were used to generate COL10A1 knockout hiPSCs using the dual sgRNA CRISPR/Cas9 system.”
MethodInoue, S., Nishimura, K., Gima, S., Nakano, M., & Takata, K. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00839 · Cited by 10
Yoo, D. H., Im, Y. S., Oh, J. Y., Gil, D., & Kim, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-32567-8 · Cited by 13
“Here we show that dissociation of hPSCs immediately activates ERK, which subsequently activates RSK and induces DUSP6, an ERK‑specific phosphatase.”
Soma, H., Sakai, D., Nakamura, Y., Tamagawa, S., Warita, T., Schol, J., Matsushita, E., Naiki, M., Sato, M., & Watanabe, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316713 · Cited by 10
Ichimura, T., Kakizuka, T., Taniguchi, Y., Ejima, S., Sato, Y., Itano, K., Seiriki, K., Hashimoto, H., Sugawara, K., Itoga, H., et al. (2025) · eLife · doi:10.7554/elife.93633.3 · Cited by 12
Effect of spacer length and type on the biological activity of peptide–polysaccharide matrices
Kumai, J., Hozumi, K., Yamada, Y., Katagiri, F., Kikkawa, Y., & Nomizu, M. (2015) · Biopolymers · doi:10.1002/bip.22785 · Cited by 10
Chang, Y., Abe, K., Yokota, H., Sudo, K., Nakamura, Y., Chu, S., Hsu, C.-Y., & Tsai, M. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8857568 · Cited by 10
Murakami, K., Yoshimura, M., Nakagawa, S., Kume, T., Kondo, T., Inoue, H., & Irie, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041179 · Cited by 10
“Human iPS cells of Alzheimer’s patients were generated as described from skin fibroblasts [43,57] and maintained using StemFit AK02N medium (Ajinomoto, Tokyo, Japan) [64] and expanded for neural differentiation.”
MethodVesicular Glutamate Release from Feeder-FreehiPSC-Derived Neurons
Baldassari, S., Cervetto, C., Amato, S., Fruscione, F., Balagura, G., Pelassa, S., Musante, I., Iacomino, M., Traverso, M., Corradi, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810545 · Cited by 10
SOX10-Nano-Lantern Reporter Human iPS Cells; A Versatile Tool for Neural Crest Research
Horikiri, T., Ohi, H., Shibata, M., Ikeya, M., Ueno, M., Sotozono, C., Kinoshita, S., & Sato, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170342 · Cited by 10
“Generated SOX10-NL iPS cells were maintained on iMatrix-511 (Nippi) coated plates with StemFit AK03N (Ajinomoto) as described under feeder-free culture system [19].”
Gima, S., Oe, K., Nishimura, K., Ohgita, T., Ito, H., Kimura, H., Saito, H., & Takata, K. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.019 · Cited by 10
Supakul, S., Oyama, C., Hatakeyama, Y., Maeda, S., & Okano, H. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.018 · Cited by 10
Cheng, Y.-S., Taniguchi, Y., Yunoki, Y., Masai, S., Nogi, M., Doi, H., Sekiguchi, K., & Nakagawa, M. (2023) · Regenerative Therapy · doi:10.1016/j.reth.2023.12.008 · Cited by 9
Insoluble Microenvironment Facilitating the Generation and Maintenance of Pluripotency
Chen, X., Li, J., Huang, Y. H., Liu, P., & Fan, Y. (2018) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2017.0415 · Cited by 9
Yasui, R., Sekine, K., Yamaguchi, K., Furukawa, Y., & Taniguchi, H. (2021) · Stem Cells · doi:10.1002/stem.3326 · Cited by 10
“Ff-I01s04 (Ff01), 1383D6, and 1231A3 hiPSCs were kindly provided by Center for iPS Cell Research and Application.(24) TkDA3-4 hiPSC was kindly provided by University of Tokyo.”
MethodInduced pluripotent stem (iPS) cells from human fetal stem cells
Guillot, P. V. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.08.007 · Cited by 9
“techniques use for example minicircle DNA, transposons, RNA viral vectors, acid-free methods, and episomal vectors, with episomal reprogramming being at present the most efficient method and the most likely translatable technology for producing clinical-grade human iPS cells via ectopic expression of transcription fac…”
MethodTorizal, F. G., Horiguchi, I., & Sakai, Y. (2019) · The Open Biomedical Engineering Journal · doi:10.2174/1874120701913010041 · Cited by 11
Kasai, K., Tohyama, S., Suzuki, H., Tanosaki, S., Fukuda, K., Fujita, J., & MIYATA, S. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110788 · Cited by 9
A Preview of Selected Articles
Atkinson, S. P. (2017) · Stem Cells · doi:10.1002/stem.2745 · Cited by 9
Induced pluripotent stem cells in companion animals: how can we move the field forward?
Barrachina, L., Arshaghi, T. E., O’Brien, A., Ivanovska, A., & Barry, F. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1176772 · Cited by 11
Gao, P., Inada, Y., Hotta, A., Sakurai, H., & Ikeya, M. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03691-7 · Cited by 8
“Briefly, iPSCs (1231A3) [27] were maintained in StemFit AK03N (Ajinomoto, Japan) supplemented with 10 µM Y27632 (Wako Pure Chemical, Japan) in dishes pre-coated with iMatrix-511 (nippi, Japan). iNCCs were induced in StemFit Basic03 (equivalent to AK03N without basic fibroblast growth factor (FGF2),…”
MethodIshikura, M., Muraoka, Y., Hirami, Y., Tu, H., & Mandai, M. (2024) · Cureus · doi:10.7759/cureus.64962 · Cited by 14
Pretemer, Y., Gao, Y., Kanai, K., Yamamoto, T., Kometani, K., Ozaki, M., Nishigishi, K., Ikeda, T., Xu, H., Hotta, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62523-1 · Cited by 11
Abdellaoui-Soussi, F. E., Brusilovsky, M., Buck, E., Bacon, W. C., Dadgar, S., Fullerton, A. M., Durban, V. M., Barrile, R., Helmrath, M. A., Takebe, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202508584 · Cited by 16
One-step induction of photoreceptor-like cells from human iPSCs by delivering transcription factors
Otsuka, Y., Imamura, K., Oishi, A., Kondo, T., Suga, M., Yada, Y., Shibukawa, R., Okanishi, Y., Sagara, Y., Tsukita, K., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103987 · Cited by 12
Ochieng, B. O., Zhao, L., & Ye, Z. (2023) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2023.0175 · Cited by 14
Zhao, M., Taniguchi, Y., Shimono, C., Jonouchi, T., Cheng, Y.-S., Shimizu, Y., Nalbandian, M., Yamamoto, T., Nakagawa, M., Sekiguchi, K., et al. (2024) · Advanced Science · doi:10.1002/advs.202308306 · Cited by 8
Matsushita, T., Onishi, A., Matsuyama, T., Masuda, T., Ogino, Y., Kageyama, M., Takahashi, M., & Uchiumi, F. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308743 · Cited by 10
“The human iPSC lines 1231A3 and M8 were established and provided by the Center for iPS Cell Research and Application (CiRA), Kyoto University (Kyoto, Japan) [17] and RIKEN (Wako, Japan) [18], respectively.”
MethodIchishima, J., Suzuki, N. M., Samata, B., Awaya, T., Takahashi, J. B., Hagiwara, M., Nakahata, T., & Saito, M. K. (2019) · Journal of Human Genetics · doi:10.1038/s10038-019-0574-8 · Cited by 9
Effect of liquid flow by pipetting during medium change on deformation of hiPSC aggregates
Kato, Y., Matsumoto, T., & Kino‐oka, M. (2019) · Regenerative Therapy · doi:10.1016/j.reth.2019.03.004 · Cited by 12
“The hiPSC lines, 1383D2 and Tic, used in this study were obtained from the Center for iPS Cell Research and Application in Kyoto University [24] and Japanese Collection of Research”
MethodXeno‐Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin‐521
Skorik, C., Mullin, N. K., Shi, M. A., Zhang, Y., Hunter, P., Tang, Y., Hilton, B. M., & Schlaeger, T. M. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.103 · Cited by 9
“This feature of Laminin has allowed some groups to passage apparently normal hiPSCs using single cell dissociation and very high split ratios (Miyazaki & Kawase, 2015) (Nakagawa et al., 2014).”
MethodInfluentialHattori, A., Ohta, E., Nagai, M., Iwabuchi, K., & Okano, H. (2021) · Methods · doi:10.1016/j.ymeth.2021.04.019 · Cited by 8
Kawase, E., Takada, K., Nakatani, R., Yamazaki, S., & Suemori, H. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102383 · Cited by 9
Highly Sensitive Detection of Human Pluripotent Stem Cells by Loop-Mediated Isothermal Amplification
Yasui, R., Matsui, A., Sekine, K., Okamoto, S., & Taniguchi, H. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10402-3 · Cited by 10
Al-Akashi, Z., Zujur, D., Kamiya, D., Kato, T., Kondo, T., & Ikeya, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089945 · Cited by 10
“For the present study, hiPSCs (1231A3) reprogrammed by episomal vectors (Nakagawa et al., 2014), RPCiPS771-2 reprogrammed by RNA (Stemgent), Ff-XT28s05-Abo_To reprogrammed by episomal vectors and knockout of HLA-A,B, and CIITA genes (provided by CiRA Foundation) were cultured in plastic dishes coated with iMatrix-511…”
MethodIsoda, M., Sanosaka, T., Tomooka, R., Mabuchi, Y., Shinozaki, M., Andoh-Noda, T., Banno, S., Mizota, N., Yamaguchi, R., Okano, H., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04995-9 · Cited by 7
Nakade, K., Tsukamoto, S., Nakashima, K., An, Y., Sato, I., Li, J., Shimoda, Y., Hemmi, Y., Miwa, Y., & Hayashi, Y. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100662 · Cited by 10
Tateno, H., Hiemori, K., Hirayasu, K., Sougawa, N., Fukuda, M., Warashina, M., Amano, M., Funakoshi, T., Sadamura, Y., Miyagawa, S., et al. (2017) · Regenerative Therapy · doi:10.1016/j.reth.2016.12.002 · Cited by 9
“Ff-I01 hiPSCs generated from human adult peripheral blood mononuclear cells by plasmid vectors [17] were obtained from the Center for iPS Cell Research and Application (CiRA), Kyoto University and maintained on cell culture plates coated with iMatrix-511 (Nippi) in StemFitAK03 media (Ajinomoto) [18].”
MethodHair follicle-derived mesenchymal cells support undifferentiated growth of embryonic stem cells
de Oliveira, V. C. C., dos Santos, D. S., Vairo, L., Kasai-Brunswick, T. H., Pimentel, L. A. S., Carvalho, A. B., de Carvalho, A. C. C., & Goldenberg, R. C. D. S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4195 · Cited by 8
“However, effective alternatives to xenogenic-based culture systems must be developed if therapies using cell types derived from pluripotent cells are to become a clinical reality (4,5).”
BackgroundMethodIn Vitro Evaluation of Exon Skipping in Disease-Specific iPSC-Derived Myocytes
Zhao, M., Shoji, E., & Sakurai, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8651-4_11 · Cited by 8
Kagihiro, M., Fukumori, K., Horiguchi, I., Kim, M., & Kino‐oka, M. (2019) · Biochemical Engineering Journal · doi:10.1016/j.bej.2019.107465 · Cited by 10
Yamazaki, D., Konishi, Y., Morikawa, T., Kobara, H., Masaki, T., Hitomi, H., Osafune, K., Nakano, D., Kittikulsuth, W., & Nishiyama, A. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13205 · Cited by 10
Takada, H., Kaieda, A., Tawada, M., Nagino, T., Sasa, K., Oikawa, T., Oki, A., Sameshima, T., Miyamoto, K., Miyamoto, M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01100 · Cited by 8
Purification technologies for induced pluripotent stem cell therapies
Generali, M., Fujita, Y., Kehl, D., Hirosawa, M., Emmert, M. Y., TAKAHASHI, J. C., Hoerstrup, S. P., & Saito, H. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00220-2 · Cited by 11
“…adhesion substrates are generally designed to simulate specific stem cell niches, replicating the biologically pertinent extracellular matrix with integral adhesion molecules such as fibronectin, vitronectin and laminin, fostering stem cell growth, maintenance 22 and in vitro differentiation 23 .”
Phase separated condensates of ATRX regulate neural progenitor identity
Tomooka, R., Sanosaka, T., Miyagi, T., Andoh-Noda, T., Banno, S., Mizota, N., Kanekura, K., Okano, H., & Kohyama, J. (2025) · Nature Communications · doi:10.1038/s41467-025-61881-0 · Cited by 10
Protein Adsorption Alters Hydrophobic Surfaces Used for Suspension Culture of Pluripotent Stem Cells
Jonas, S. J., Stieg, A. Z., Richardson, W. T., Guo, S., Powers, D. N., Wohlschlegel, J. A., & Dunn, B. (2015) · The Journal of Physical Chemistry Letters · doi:10.1021/jz502520r · Cited by 8
Leishmania tarentolae for the Production of Multi-subunit Complexes
Niimi, T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-27216-0_10 · Cited by 7
Isolation and analysis of laminins
Aumailley, M. (2017) · Methods in cell biology · doi:10.1016/bs.mcb.2017.08.011 · Cited by 7
Yumoto, T., Kimura, M., Nagatomo, R., Sato, T., Utsunomiya, S., Aoki, N., Kitaura, M., Takahashi, K., Takemoto, H., Watanabe, H., et al. (2020) · Molecular Autism · doi:10.1186/s13229-020-00373-y · Cited by 12
“Feeder-free 201B7 human iPSCs [34, 35] were purchased from iPS Academia Japan Inc.”
MethodStabilized generation of human iPSC-derived liver organoids using a modified coating approach
Kamishibahara, Y., Okamoto, S., Ohkuma, T., & Taniguchi, H. (2022) · Biology Methods and Protocols · doi:10.1093/biomethods/bpac034 · Cited by 8
Current Application of iPS Cells in the Dental Tissue Regeneration
Hamano, S., Sugiura, R., Yamashita, D., Tomokiyo, A., Hasegawa, D., & Maeda, H. (2022) · Biomedicines · doi:10.3390/biomedicines10123269 · Cited by 11
“MEFs were essential as feeder cells for the initial subculture of iPS cells.”
BackgroundEfficient passage of human pluripotent stem cells on spider silk matrices under xeno-free conditions
Wu, S., Johansson, J., Hovatta, O., & Rising, A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2053-5 · Cited by 8
Nakabayashi, H., Aoyama-Ishiwatari, S., Kawahara, M., & Nagamune, T. (2016) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2016.02.010 · Cited by 11
Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9
Higashioka, K., Koizumi, N., Sakurai, H., Sotozono, C., & Sato, T. (2017) · Stem Cells International · doi:10.1155/2017/9210494 · Cited by 8
“MYOG-deficient iPS cells were maintained on SNL feeder cells or iMatrix-511 (Nippi, Tokyo, Japan)coated plates with StemFit AK03N (Ajinomoto, Tokyo, Japan) under a feeder-free culture system [20].”
MethodSubpopulations of fibroblasts derived from human iPS cells
Kobayashi, T., Yamashita, A., Tsumaki, N., & Watanabe, H. (2024) · Communications Biology · doi:10.1038/s42003-024-06419-8 · Cited by 8
Metadata
- Authors
- Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., Yoshida, Y., Toyoda, T., Osafune, K., Sekiguchi, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- Institute for Protein Research, The University of Osaka (JP)
- Ajinomoto (Japan) (JP)
- Gladstone Institutes (US)
- Corresponding author
- Nakagawa, Masato
- ORCID
- Venue
- Scientific Reports
- Published
- 2014-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 3594-3594
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3884228
- OpenAlex
- W1972564906
- Cited by
- 673
- References
- 30
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 74 · 2023: 66 · 2022: 65 · 2021: 76 · 2020: 66 · 2019: 49 · 2018: 37 · 2017: 58 · 2016: 47 · 2015: 39 · 2014: 14
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- OUKA (Osaka University Knowledge Archive) (Osaka University) (submittedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (25860747, 24790277, 24590353, 24592124, 25291026)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, feeder-free culture, xeno-free culture, human embryonic stem cells, primary fibroblasts, blood cells, karyotype stability, cell dissociation, differentiation potential
- MeSH terms
- Cell Differentiation, Culture Media, Humans, Serial Passage, Cell Culture Techniques, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.